Article
Alzheimer's disease. Molecular consequences of presenilin-1 mutation.
Nature - 7 Jun 2001
Gandy S, Naslund J, Nordstedt C
Abstract excerpt
Alzheimer's disease is characterized by accumulation in the brain of a family of insoluble amyloid peptides (Abeta peptides), which are produced as a result of the normal processing of beta-amyloid precursor protein (beta-APP). Russo et al. claim that a truncated Abeta peptide that lacks the first ten amino acids accumulates in the brains of patients carrying a mutant form of pre-senilin 1 (PS1), a protein that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
